Relationship of p22phox C242T polymorphism with nephropathy in type 2 diabetic patients

Journal of Nephrology

Volumn 18, Issue 6, 2005, Pages 733-738

  Santos, Kátia G ^a   Canani, Luís H ^b   Gross, Jorge L ^b   Tschiedel, Balduíno ^c   Souto, Kátia E ^c   Roisenberg, Israel ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Hospital N Sra Conceição   (Brazil)

Author keywords

Diabetic nephropathy; p22phox; Polymorphism; Type 2 diabetes

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ALLELE; ANALYSIS OF VARIANCE; ARTICLE; BRAZIL; CASE CONTROL STUDY; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NADPH OXIDASE; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS;

EID: 30644459092     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gross JL, Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005; 28: 164-76.
2. Bo S, Ciccone G, Rosato R, Gancia R, Grassi G, Merletti F, Pagano GF. Renal damage in patients with type 2 diabetes: a strong predictor of mortality. Diabet Med 2005; 22: 258-65.
3. Fogarty DG, Hanna LS, Wantman M, Warram JH, Krolewski AS, Rich SS. Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000; 49: 1057-63.
4. Lindner TH, Monks D, Wanner C, Berger M. Genetic aspects of diabetic nephropathy. Kidney Int Suppl 2003; 84: S186-91.
5. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 2004; 287: R1014-30.
6. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 2001; 88: E14-22.
7. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003; 14 (suppl 3): S221-6.
8. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H. Increased expression of NAD (P) H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats andits reversibility by interventive insulin treatment. Diabetologia 2003; 46: 1428-37.
9. Ellis EA, Grant MB, Murray FT, Wachowski MB, Guberski DL, Kubilis PS, Lutty GA. Increased NADH oxidase activity in the retina of the BBZ/WOR diabetic rat. Free Radic Biol Med 1998; 24: 111-20.
10. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Arterioscler Thromb Vasc Biol 2002; 22: 1838-44.
11. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon EM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000; 86: E85-90.
12. Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 2004; 24: 1031-6.
13. Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22phox): gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulo-matous disease. J Clin Invest 1990; 86: 1729-37.
14. Matsunaga-Irie S, Maruyama T, Yamamoto Y, Motohashi Y, Hirose H, Shimada A, Murata M, Saruta T. Relation between development of nephropathy and the p22phox C242T and receptor for advanced glycation end product G1704T gene polymorphisms in type 2 diabetic patients. Diabetes Care 2004; 27: 303-7.
15. Hayaishi-Okano R, Yamasaki Y, Kajimoto Y, Sakamoto K, Ohtoshi K, Katakami N, Kawamori D, Miyatsuka T, Hatazaki M, Hazama Y, Hori M. Association of NAD(P)H oxidase p22phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 2003; 26: 458-63.
16. Nakano T, Matsunaga S, Nagata A, Maruyama T. NAD(P)H oxidase p22phox gene C242T polymorphism and lipoprotein oxidation. Clin Chim Acta 2003; 335: 101-7.
17. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
18. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157: 2413-46.
19. Shimokata K, Yamada Y, Kondo T, Ichihara S, Izawa H, Nagata K, Murohara T, Ohno M, Yokota M. Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 2004; 172: 167-73.
20. Senti M, Aubo C, Tomas M. Differential effects of smoking on myocardial infarction risk according to the Gln/Arg 192 variants of the human paraoxonase gene. Metabolism 2000; 49: 557-9.
21. Zelmanovitz T, Gross JL, Oliveira JR, Paggi A, Tatsch M, Azevedo MJ. The receiver operating characteristics curve in the evaluation of a random urine specimen as a screening test for diabetic nephropathy. Diabetes Care 1997; 20: 516-9.
22. Rose GA, Blackburn H, Gillium RF, Prineas RJ. Cardiovascular survey methods (Monograph series no. 56). Geneva: World Health Organization 1982; 123-43.
23. Beck MO, Silveiro SP, Friedman R, Clausell N, Gross JL. Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care 1999; 22: 1745-7.
24. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991; 19: 5444.
25. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphisin of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 1998; 97: 135-7.
26. Hodgkinson AD, Millward BA, Demaine AG. Association of the p22phox component of NAD(P)H oxidase with susceptib-ility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 2003; 26: 3111-5.
27. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000; 102: 1744-7.
28. Whitehead AS, FitzGerald GA. Twenty-first century phox: not yet ready for widespread screening. Circulation 2001; 103: 7-9.
29. Gardemann A, Mages P, Katz N, Tillmanns H, Haberbosch W. The p22phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals. Atherosclerosis 1999; 145: 315-23.